ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Activity

21 hedge funds and large institutions have $2.87M invested in Enlivex Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-5
Holders Change %
-19.23%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
8
Closed
8
Calls
$101K
Puts
$8K
Net Calls
+$93K
Net Calls Change
+$55K

Top Buyers

1
Group One Trading
Group One Trading
Illinois
+$7.84K
2
Bank of America
Bank of America
North Carolina
+$3.16K
3
SWM
Spire Wealth Management
Virginia
+$560
4
Raymond James Financial
Raymond James Financial
Florida
+$64

Top Sellers

1
AC
Armistice Capital
New York
-$413K
2
Citadel Advisors
Citadel Advisors
Florida
-$68K
3
Millennium Management
Millennium Management
New York
-$63.6K
4
TSS
Two Sigma Securities
New York
-$27.5K
5
Jane Street
Jane Street
New York
-$22.1K
Name Holding Trade Value Shares
Change 		Shares
Change %
Geode Capital Management
26
Geode Capital Management
Massachusetts
– -$10.1K -10,420 Closed
HF
27
HRT Financial
New York
– -$9K -10,178 Closed
Simplex Trading
28
Simplex Trading
Illinois
– -$1K -1,063 Closed
UBS Group
29
UBS Group
Switzerland
– -$16 -16 Closed
1
2